Clear Street Derivatives’s Psyence Biomedical Warrant PBMWW Stock Holding History

Clear Street Derivatives’s Portfolio PBMWW Stock Details PBMWW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$2.22K	Hold	109,356	–	–	0.02%	31
2025 Q1	$1.85K	Hold	109,356	–	–	﹤0.01%	62
2024 Q4	$1.57K	Sell	109,356 -168,563	-61%	-$2.24K	﹤0.01%	74
2024 Q3	$3.5K	Hold	277,919	–	–	﹤0.01%	90
2024 Q2	$2.92K	Hold	277,919	–	–	﹤0.01%	102
2024 Q1	$19.5K	Buy	+277,919	New	+$17.3K	﹤0.01%	66

Other funds holding PBMWW

HCI

Harraden Circle Investments New York $499M AUM 24.03% 1-Year Est. Return

PAMP

Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return

MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 77.9% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return

Calamos Advisors Naperville, Illinois $28.2B AUM 21.78% 1-Year Est. Return

Cantor Fitzgerald New York $6.78B AUM 29.01% 1-Year Est. Return

SCM

Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return

Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return

Clear Street Derivatives's PBMWW Position: Q2 2025 in Review

Clear Street Derivatives held its Psyence Biomedical Warrant (PBMWW) position steady in Q2 2025 at 109,356 shares worth $2.22K. The position accounts for 0.02% of the portfolio, ranked #31.

Clear Street Derivatives first reported a position in PBMWW in Q1 2024 and has held it in 6 quarters since. The position peaked at $19.5K in Q1 2024. 23 funds tracked by Wall St. Rank hold PBMWW as of Q2 2025.

Clear Street Derivatives held 109,356 shares of Psyence Biomedical Warrant worth $2.22K as of Q2 2025.
Clear Street Derivatives left its Psyence Biomedical Warrant share count unchanged in Q2 2025.
Psyence Biomedical Warrant made up 0.02% of Clear Street Derivatives's portfolio in Q2 2025, its #31 holding.
Clear Street Derivatives first reported a position in Psyence Biomedical Warrant in Q1 2024 and has held it in 6 quarters since.
Clear Street Derivatives's Psyence Biomedical Warrant position peaked at $19.5K in Q1 2024.
23 funds tracked by Wall St. Rank held Psyence Biomedical Warrant as of Q2 2025.

Based on Clear Street Derivatives's 13F filing for Q2 2025, filed 13 Aug 2025.